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The purpose of this study was to evaluate the effect of hydroxyapatite coated with β-tricalcium phosphate (HCT) in
surgically prepared one-wall periodontal intrabony defects in dogs. Four beagle dogs were used as the subjects.
One-wall intrabony defects were prepared surgically at the mandibular second and fourth premolars in both right
and left jaw quadrants. The experimental groups were divided into two, according to the kind of graft material
used. In the HCT group, the defect was filled with HCT. In the HCT/ACS group, the defect was filled with HCT
and then covered by an absorbable collagen sponge (ACS). The control group was treated by root planing only.
Histologic and histometric analyses revealed statistically significant bone formation in the HCT and HCT/ACS groups,
compared with the control group. New bone was observed along the root surface or in close contact with the
residual graft particles in the HCT and HCT/ACS groups. The HCT/ACS group showed statistically greater bone for-
mation than the HCT group. It can be concluded that HCT provides osteoconductivity in one-wall intrabony
defects. In addition, HCT in one-wall intrabony defects provide new cementum formation and periodontal ligament
fiber formation with neither root resorption nor ankylosis.
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Introduction
eriodontal osseous defects can be treated by various pro-
cedures, including guided tissue regeneration,1) bone graft-
ing,2) root surface conditioning,3) and the use of growth factors
such as platelet-derived growth factor4) for regeneration of
destroyed periodontal tissue. Many investigations have demon-
strated that bone grafting reduces the probing depth and gains
periodontal tissue attachment and the filling of defects in clin-
ical situations.5) Among the available bone graft materials,
autogenous bone is the first choice because of its osteogenic
effect and the lack of host immune response. However, the
use of autogenous grafts is limited by the amount of available
host tissue, and it is associated with external root resorption
and ankylosis.6) To overcome these disadvantages, the use of
synthetic bone grafts has been proposed for the treatment of
periodontal defects.
Hydroxyapatite (HA) is well known for its biocompatibility
and osteoconductivity; it acts as a scaffold.7) It has been used
clinically for the treatment of periodontal intrabony defects.8-9)
However, disadvantages of its use have been reported, such as
a low rate of biodegradability and low mechanical strength.10-11)
Although β-tricalcium phosphate (β-TCP) shows greater resorb-
ability than HA and permits replacement with bone in animal
and human experiments,12-13) because of its rapid rate of re-
sorption, which exceeds that of autogenous bone, it demon-
strates an unpredictable rate of degradation and osteocon-
ductivity.14-16) An ideal synthetic bone substitute should pro-
vide a scaffold for bone formation and have resorptive proper-
ties that allow replacement with new bone.17) Accordingly,
many studies have suggested the use of so-called biphasic cal-
cium phosphate (BCP), which combines the scaffolding prop-
erties of HA and the resorbability of β-TCP.18) 
Currently, BCP is widely used as an alternative to autogenous
bone for ridge augmentation19) and maxillary sinus grafting20-21) in
dentistry, because it does not require production of an additional
surgical site and can be supplied in unlimited amounts. In
addition, it has demonstrated favorable osteoconductivity in
clinical and animal studies.22-23)
It has been reported that the biologic activity of BCP,
manifest by the dissolution rate and osteoconductivity, differs
according to its HA/β-TCP ratio and porosity.24-25) In an effort
to improve the osteoconductivity of BCP, various manufacturing
methods that change the combination ratio, porosity, and
crystallinity of BCP have been evaluated. Conventional BCP is
P
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generally prepared by mixing HA and β-TCP and then sintering
it at 700oC or above.26) A novel method has been developed
recently for the fabrication of BCP, which involves coating the
HA scaffold surface with β-TCP by the sol-gel technique. The
HA is coated with β-TCP in order to provide convenient and
stable environment for cell attachment, proliferation. This is
caused by an increased release of ions owing to the resorption
of β-TCP during the early implantation phase in vivo. Ioku et
al.27) have reported the behavior in vivo of porous HA coated
with β-TCP, which showed higher compressive strength than
the original porous HA. In addition, resorption of coated β-
TCP resulted in precipitation of apatite on the porous HA. It
has been reported that a coating of calcium phosphate on a
porous scaffold resulted in enhanced cell proliferation and
differentiation.28) Kim et al.
22) also demonstrated that HA coated
with β-TCP led to successful bone regeneration in a human
sinus graft procedure.22) On the basis of previous studies, we
assumed that HA coated with β-TCP (HCT) would be
favorable to bone formation. However, there is a lack of histo-
logic and histometric studies that evaluate the regeneration of
HCT in a well-established animal model. 
The purpose of this study was to evaluate the regenerative




Four male beagle dogs, each weighing 10-15 kg and approxi-
mately 2 years old, were used. Animal selection, management,
preparation, and the surgical protocol followed the routine
procedures approved by the Animal Care and Use Commit-
tee, Yonsei Medical Center, Seoul, Korea.
The BCP that was investigated in this study was HA coated
with β-TCP (HCT) (Osteon™; Genoss, Suwon, Korea). The
HCT is composed of 70% HA and 30% β-TCP. It has a total
porosity of approximately 77% and a particle size of 0.5-1.0 mm.
To prepare HCT, porous HA was produced by a stretched
polymeric sponge method. Subsequently, the HA was soaked in
calcium/phosphate sol-gel, followed by sintering at 1000oC.29-30)
An absorbable collagen sponge (ACS) (Collatape®, Zimmer
Dental, USA) was used to cover the bone substitute in the intra-
bony defects. 
Surgical Protocol
Surgery was performed under general anesthesia induced by
intravenous injection of atropine (Kwang-myung Pharmaceutical
Ind., Seoul, Korea) 0.05 mg/kg and intramuscular injection of a
combination of xylazine (Rompun, Bayer Korea, Seoul, Korea)
2 mg/kg and ketamine (Ketalar, Yuhan, Seoul Korea) 10 mg/kg,
followed by inhalation anesthesia (Gerolan, Choongwae Pharma-
ceutical, Seoul, Korea). Local infiltrative anesthesia (2% lidocaine
HCl with epinephrine 1:100 000, Kwangmyung Pharm., Seoul,
Korea) was used at the surgical sites. Two months prior to sur-
gery, both the mandibular first and third premolars had been
extracted in order to create surgical sites. After complete heal-
ing of the extraction sockets, the mucoperiosteal flaps were
reflected and one-wall intrabony defects (4 × 4 mm) were pre-
pared surgically at the distal aspect of the second and the
mesial aspect of the fourth mandibular premolars in both right
and left jaw quadrants (Figure 1(B)).31) Careful debridement
and root planing was performed to ensure complete removal
of the cementum from above the base of the defect. A refer-
ence notch was made on the root surface at the bottom of the
intrabony defect using a round bur. The unilateral mandibular
defects each underwent one of the two experimental protocols:
implantation of HCT (HCT group) or HCT/ACS (HCT/ACS group).
The contralateral mandibular defect received root planing
only (control group). The experimental protocols were rotated
between the defect sites in subsequent animals. The remaining
Figure 1. (A) HA coated with β-TCP (HCT), (B) Clinical photograph showing a surgically prepared one-wall intrabony defect of the
mesial fourth premolar filled with HCT before covering with ACS.
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defects were not included in this study. The defects were filled
with the experimental implants to the level of the alveolar
crest. In the HCT/ACS group, the defects were filled with HCT
and then covered by ACS. After treatment of the defect, the
flaps were sutured with 5-0 resorbable suture material (Polygla-
ctin 910, braided absorbable suture, Ethicon, Johnson & Johnson
Int., Edinburgh, U.K.). Postsurgical treatment included intra-
muscular antibiotics for 3 days and daily dressing with 0.2%
chlorhexidine solution (Hexamedin, 2% chlorhexidine, Bukwang
Pharm., Seoul, Korea) for 7 days. The sutures were removed
after 10 days. The animals were killed 8 weeks after surgery by
an overdose of pentobarbital sodium (90~120 mg/kg; i.v.). Sam-
ples were collected from the defect sites and block sections
were prepared for histologic and histometric evaluation. 
Histologic Analysis
The block sections were fixed in 10% buffered formalin and
decalcified with 5% nitric acid for 14 days. Paraffin wax blocks
were made and sectioned in the mesio-distal direction with a
thickness of 4 µm. Each section was stained with hematoxylin-
eosin and observed with a light microscope. 
Histometric Analysis
Histometric analysis was performed using a software pro-
gram (Image-Pro Plus®, Media Cybernetics, Silver Spring, MD,
USA). The cement–enamel junction and the apical notch were
used as reference points. The histometric parameters were as
follows: defect height (DH), epithelial attachment (EA), con-
nective tissue attachment (CA), newly formed cementum (NC),
and newly formed bone height (NB) (Figure 2). 
Statistical Analysis
The mean and standard deviation were calculated for each
group. The significance of the differences among the groups
was determined by the Kruskal–Wallis test (p < 0.05). The Bon-




During the postoperative period, there were no adverse
effects on healing in any group. There were no signs of inflam-
mation or wound exposures. 
Histologic Observations
Control Group
The histologic examination showed limited formation of
new bone and cementum above the reference notch (Figure
3(A)). Inflammatory cell infiltration occurred minimally at the
surgical sites. There were no signs of ankylosis or root resorp-
tion in any of the specimens.
HCT Group
Histologic analysis of the HCT group demonstrated more
regeneration of bone and cementum compared with the con-
trol group. Regenerated bone was observed prominently along
the root surface (Figure 3(B)). The remaining graft material was
surrounded by immature woven bone and connective tissue.
Regenerated cementum and the periodontal ligament space
were also observed along the root surface, with no root
resorption or root ankylosis. 
HCT/ACS Group
Greater new bone formation and cementum regeneration
were observed in this group than in both the control and the
HCT groups. As shown in (Figure 4(A)), the regenerated bone
was primarily formed of woven bone and contained many
osteocytes. The remaining graft particles were closely contacted
to the regenerated bone or were surrounded by loose con-
nective tissue. Osteoblast-like cells were arranged along the
regenerated woven bone. New bone also could be observed
at the inner portion of remaining graft particles and vascular
structures could be seen within the loose connective tissue.
Figure 2. Schematic drawing describing the landmarks and
parameters used in the histometric analysis. DH: defect height,
EA: epithelial attachment, CA: connective tissue attachment,
NC: newly formed cementum, NB: newly formed bone height,
PDL: periodontal ligament.
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Multi-nucleated giant cells were observed around the remaining
graft particles (Figure 4(B)). New cementum that was thinner
than the original cementum was observed along the root sur-
face, and it extended to the level of the regenerated bone
(Figure 5). 
Periodontal ligament spaces were observed between the
regenerated bone and the cementum, from the apical notch to
the level of attachment of the coronal connective tissue (Figure
5). Periodontal ligament fibers were obliquely or perpendiculary
inserted into the newly formed cementum and bone (Figure 5).
Histometric Analysis
The results of the histometric analyses are summarized in
Table I. The average difference in the height of the defect was
not statistically significant among the groups. In the HCT group,
there was significantly more bone formation than in the con-
trol group. There was also significantly more bone formation
in the HCT/ACS group than in either the control or the HCT
group. Significantly more cementum regeneration was observed
in the HCT/ACS than in the HCT group. 
Discussion
The present study evaluated the regenerative effect of HCT
in surgically prepared one-wall intrabony defects in dogs. This
newly developed BCP contains an HA/β-TCP ratio of 70/30.
The optimal ratio of HA/β-TCP has not yet been determined.
As Nery et al. demonstrated that a HA/β-TCP ratio of 85/15
Figure 3. (A) Control group. A limited amount of bone formation is observed above the notch, (B) Histologic view of HCT group.
More bone formation is observed than control. There were remnants of graft material present, (C) Histologic view of HCT/ACS
group. Marked bone formation was observed above the notch along the root surface. The remaining graft materials were seen as
hollow unresorbed pores (hematoxylin and eosin staining: original magnification × 20, reference notch: arrow head, highest point of
new bone: arrow).
Figure 4. High magnification of HCT/ACS group: (A) At the third box on the left in Figure 3., woven bone was embedded in loose
connective tissue or was observed in direct contact with the graft material. There was also new bone in the inner portion of
remaining graft materials, (B) At the second box on the left in Figure 3., multi-nucleated giant cells (arrow) were observed in the
remaining HCT (hematoxylin and eosin staining: original magnification, A: × 100, B: × 200, NB: new bone, GM: graft material).
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showed greater periodontal tissue attachment and bone
regeneration in periodontal osseous defects,18) BCP with an
HA/β-TCP ratio of 70/30 also led to predictable bone forma-
tion in a rat calvarial defect.32) Meanwhile, the biomaterial used
in this study has an interconnected porous structure similar to
that of human cancellous bone, with a porosity of 77% and a
pore size of 300-500 µm under scanning electron micros-
copy.22) Shetty et al. suggested that interconnectivity of bone sub-
stitutes is essential for bone ingrowth.17) According to Legeros and
Fleckenstein, macroporosity (diameter > 100 µm) provides a scaf-
fold that facilitates bone-cell colonization more successfully than
microporosity (diameter < 10 µm).26,32) Considering the findings
of these previous studies, it is thought that the HCT utilized in this
study fulfills the physical and structural requisites for bone
regeneration. 
The biologic rationale for the choice of the one-wall
intrabony defect model in dogs was as follows. The wound
healing response in periodontal defects in experimental models
involving dogs and monkeys appears to be comparable to that
in the human.33-34) One-wall intrabony defects are recognized
to be a useful and reproducible model for the evaluation of
bone substitute osteoconduction in dogs.35) Many bone sub-
stitute candidates have already been evaluated in one-wall
intrabony defects to verify their osteoconductivity and peri-
odontal regeneration.35-38)
The histologic and histometric results of this study indicated
that the HCT resulted in greater bone formation than in the
control group, a difference that was statistically significant. In
the HCT group, regenerated bone was observed along the
root surface and it extended in the coronal direction. This
new bone was originated from mesenchymal cells in the
periodontal ligament space and osteogenic precursor cells in
the base of intrabony defects.31) The HCT/ACS group showed
significantly greater bone formation than the HCT and control
groups. The ACS used in the HCT/ACS group has the
biological property to be absorbed in about 10-14 days in
vivo. It seemed that the ACS contributed to stabilization of the
bone substitute particles and prevented the ingrowth of soft
tissue into the defect at an early phase of healing. Conse-
quently, greater bone formation was seen in the HCT that was
covered with ACS. 
Osteoconductive biomaterial should be resorbable in order
to provide space for cell attachment, proliferation, and vascu-
larization. A number of multi-nucleated giant cells were also
detected adjacent to the remaining graft material and newly
formed bone. It has been suggested that dissolution of BCP
results from the phagocytosis of multi-nucleated giant cells and
leads to bone replacement.39-40) The histologic findings of this
study indicated that the HCT was under active resorption,
which may be associated with biologic phagocytosis of multi-
nucleated giant cells, followed by bone ingrowth. 
Yamada et al. reported that BCP might be degraded by a dif-
ferent mechanism, specifically by osteoclastic resorption, based
on the detection of resorption lacunae on the BCP surface in
vitro.41) They suggested that this osteoclastic resorption contrib-
utes to osteoblastic bone formation on the surface of the β-TCP.
Osteoclast-like cells have been identified on the surface of BCP
in another histologic study.42) However, we could not identify
the numerous multi-nucleated giant cells on the HCT surface as
true osteoclast cells and further study is required in order to
explain the relationship between resorption of the HCT and
osteoclastic cell activity.
It has been reported that BCP, when implanted in vivo,
Figure 5. High magnification of first box on the left in Figure 3.
Periodontal ligament fibers were obliquely or perpendicularly
inserted into the newly formed cementum and bone in the
notch area (hematoxylin and eosin staining: original magnifi-
cation × 200, NB: new bone, PDL: periodontal ligament fiber,
new cementum:arrow).
Table 1. Comparison of histometric analysis between all groups 
(mean ± SD in mm)
Control HCT HCT/ACS
Defect height 4.31 ± 0.76 4.20 ± 0.34 4.55 ± 0.32
New bone height 0.30 ± 0.38 1.40 ± 0.72∗ 2.42 ± 0.34∗§
New cementum height 2.78 ± 0.83 1.63 ± 0.54 2.66 ± 0.30§
Epithelial attachment 1.43 ± 0.38 1.30 ± 0.55 1.58 ± 0.63§
Connective tissue attachment 0.07 ± 0.14 0.65 ± 0.29∗ 0.32 ± 0.32∗
* Significant statistical difference from control (p < 0.05)
§ Significant statistical difference from HCT (p < 0.05)
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became degraded and absorbed into the surrounding environ-
ment with the release of calcium and phosphate ions. When
these released ions reached a supersaturation state in the
microenvironment, bone apatite began to precipitate on the
surface of the BCP.24,26) In our histologic study, the inner sur-
face of HCT was relatively rough going through resorption and
new bone was observed in direct contact with the HCT.
Another study that investigated preexisiting BCP also demon-
strated similar histologic results.42-43) Moreover, new bone
ingrowth was observed at the inner portion of HCT in higher
magnified histologic views of HCT/ACS group (Figure 4(A)).
This means that for bone formation the HCT showed resorp-
tive property for cell attachment, ingrowth as well as scaffold-
ing activity.
The bone regeneration capacity of HCT in our study corre-
sponds to the findings reported by other investigators. Accord-
ing to Um et al., the HCT used in this study induced new
bone formation in a rabbit calvarial defect that was compara-
ble to that induced by deproteinized bovine bone.44) When
used in a sinus grafting procedure, this HCT led to successful
bone regeneration.22)
New cementum was also observed in both experimental
groups in the current study. The HCT/ACS group, in particular,
showed significant cementum regeneration, compared with
the HCT group. In addition to cementum formation, the peri-
odontal ligament space was also well maintained between the
newly formed cementum and the alveolar bone. Periodontal
ligament fibers perpendicularly or obliquely inserted to the new
cemenum and bone could be observed in this study. Peri-
odontal regeneration comprises the formation of new cemen-
tum with insertion of periodontal ligament fibers, as well as
alveolar bone regeneration.1) It have been reported that root
resorption could be prevented by new cementum forma-
tion.45) Thus, it was found that this HCT also has beneficial
effects in periodontal regeneration. 
Conclusions
In conclusion, the results of the present study indicate that
the HCT possessed osteoconductivity and showed periodontal
regeneration in one-wall intrabony defects in dogs. The com-
bination of HCT and ACS increased bone regeneration com-
pared with HCT alone. Though the HCT showed favorable
regenerative effect, there still lacks evidence on the advantage
of coating HA with β-TCP. Therefore, further investigation to
evaluate the influence of HA coated with β-TCP on bioactivity,
including the degradation rate and cell attachment efficacy, is
necessary in vivo and in vitro. 
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